| 產品名稱 | Amycolatopsis rifamycinica Bala et al. |
|---|---|
| 商品貨號 | B201207 |
| Deposited As | Nocardia mediterranei (Margalith and Beretta) Thiemann et al. |
| Strain Designations | NT 19 [DSM 46095] |
| Application | Produces rifamycin SV |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format | freeze-dried |
| Preceptrol® | no |
| Type Strain | yes
Ref  Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 |
| Medium | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions | Temperature: 26.0°C |
| Name of Depositor | EH Baxter |
| References | Birner J, et al. An Australian isolate of Nocardia mediterranea producing rifamycin SV. J. Antibiot. 25: 356-359, 1972. PubMed: 4649865 Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
